Mostrando 2 resultados de: 2
A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans
ArticleAbstract: It has been suggested that the higher susceptibility of Hispanics to metabolic disease is related toPalabras claves:Autores:Alonzo V.A., Ana Maria Tito-Álvarez, Arellano-Campos O., Baier L.J., Barquera-Lozano R., Bonatto S.L., Bortolini M.C., Bustos-Arriaga J., Camilo S. Zurita-Salinas, Canizales-Quinteros S., Cedillo-Barrón L., de Ángeles Granados-Silvestre M., Flores-Dorantes T., Gómez-Trejo C., Gonzalez-Martin A., Gorostiza A., Granados J., Hayden M.R., Huertas-Vázquez A., Hünemeier T., Jacobo-Albavera L., Knowler W.C., Kruit J.K., León-Mimila P., Lisker R., Menjívar M., Moises R.S., Montufar-Robles I., Moreno-Estrada A., Ortiz-López M.G., Pape T.D., Ramírez-Jiménez S., Rodríguez-Cruz M., Romero-Hidalgo S., Salinas C.A.A., Salzano F.M., Sikora M., Tusié-Luna T., Vieira-Filho J.P., Villalobos-Comparan M., Villamil-Ramírez H., Villarreal-Molina T., Wang L., Zhang L.H.Fuentes:scopusGenetic variability of CYP2C9∗2 and CYP2C9∗3 in seven indigenous groups from Mexico
ArticleAbstract: Aim: CYP2C9 is one of the major drug metabolizing enzymes, however, little is known about polymorphiPalabras claves:allele frequency, CYP2C9, hypoglycemic therapy, Mexican indigenous, pharmacogenetics, polymorphismAutores:Adrián LLerena, García-Rodríguez M., Granados-Silvestre M., Menjívar M., Ortiz-López M.G., Peña-Espinoza B., Rivera-Santiago C., Sánchez-Pozos K.Fuentes:scopus